News | Heart Failure | May 22, 2024

Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium

New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham, shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC)

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham, shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC), a marker of atherosclerotic cardiovascular disease. Previous research on physical activity and CAC, which suggested that individuals who engage in high volume endurance training (such as marathoners and triathletes) have more sub-clinical atherosclerosis or CAC, has primarily relied on assessment at one point in time and was unable to track individual changes in CAC. This new study, published in the Journal of the American Medical Association Cardiology, shows that the progression of CAC over time is not associated with leisure-time aerobic physical activity measured at baseline and follow-up.

"These new insights suggest that being physically active, even at very high levels, does not appear to accelerate asymptomatic atherosclerosis progression, which might be good news for exercise enthusiasts,” said Kerem Shuval, PhD, Director of Epidemiology and Behavioral Science at The Cooper Institute and lead author of the study.

The study, which is part of the Cooper Center Longitudinal Study (CCLS), included 8,771 men and women who were 50 years old on average, at baseline (50.2 years for men and 51.1 for women). Their physical activity, CAC and other clinical measurements were determined during preventive medicine visits to Cooper Clinic in Dallas, Texas. Participants had at least two clinic visits between 1998 and 2019. Analysis of the data, which accounted for potential confounding factors, revealed that aerobic physical activity does not appear to elevate the rate of CAC progression.

“This study will assist health care providers who care for elite athletes, such as marathon runners, in managing and counseling their patients with subclinical atherosclerosis. They can feel safe in continuing to exercise as long as there are no symptoms or underlying issues," said Laura DeFina, MD, FACP, FAHA, President, CEO and Chief Science Officer of The Cooper Institute.

“This study provides important new knowledge which will greatly assist in the care of Masters athletes and highly active people who have high coronary calcium scores. Although previous work from our research team showed that there was a greater risk of having clinically significant coronary calcium in highly active people, the present analysis is reassuring that sustaining high levels of physical activity do not accelerate the progression of atherosclerosis," said co-author Benjamin Levine, MD, FACC, FAHA, FACSM, Professor of Internal Medicine at UT Southwestern Medical Center and director of the Institute for Exercise and Environmental Medicine, a collaboration between UT Southwestern and Texas Health Presbyterian Hospital Dallas.

For more information: cooperinstitute.org


Related Content

News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
News | Heart Failure

March 25, 2025 — Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive ...

Home March 25, 2025
Home
News | Heart Failure

March 17, 2025 — Bayer recently announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental new ...

Home March 21, 2025
Home
News | Heart Failure

Jan. 7, 2025 — FIRE1 recently announced it has received Breakthrough Device Designation from the U.S. Food and Drug ...

Home January 07, 2025
Home
News | Heart Failure

Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. But there are ...

Home October 02, 2024
Home
News | Heart Failure

Sept. 30, 2024 — Cytokinetics, Inc. recently announced that additional analyses synthesizing data from SEQUOIA-HCM ...

Home October 02, 2024
Home
News | Heart Failure

Sept. 18, 2024 – Astellas Pharma Inc. recently announced that Digitiva, a non-invasive digital health solution for heart ...

Home September 19, 2024
Home
News | Heart Failure

Aug. 21, 2024 — The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than rates ...

Home August 21, 2024
Home
News | Heart Failure

July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & ...

Home July 31, 2024
Home
Subscribe Now